Showing results (31-40 of 441) with videos related to
Sort By:
Pageof 45
Neurology(R) Neuroimmunology & Neuroinflammation|August 28, 2019
Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetesAri Breiner, Carolina Barnett Tapia, Leif Erik Lovblom, et al.Plos One|January 28, 2014
Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathyJustin A Lee, Elise M Halpern, Leif E Lovblom, et al.Journal of the Neurological Sciences|July 19, 2017
Uric acid levels correlate with the severity of diabetic sensorimotor polyneuropathyAlon Abraham, Ari Breiner, Carolina Barnett, et al.Diabetes Care|February 11, 2012
Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity studyAusma Ahmed, Vera Bril, Andrej Orszag, et al.Plos One|March 28, 2013
Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parametersAlanna Weisman, Vera Bril, Mylan Ngo, et al.Plos One|March 4, 2014
The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational studySamantha K Dunnigan, Hamid Ebadi, Ari Breiner, et al.Diabetes Care|September 13, 2013
Conduction slowing in diabetic sensorimotor polyneuropathySamantha K Dunnigan, Hamid Ebadi, Ari Breiner, et al.Brain and Behavior|December 24, 2013
Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDPSamantha K Dunnigan, Hamid Ebadi, Ari Breiner, et al.Diabetes Care|April 13, 2013
Structure-function relationship between corneal nerves and conventional small-fiber tests in type 1 diabetesGavasker A Sivaskandarajah, Elise M Halpern, Leif E Lovblom, et al.Neurology|May 19, 2017
Effect of omega-3 supplementation on neuropathy in type 1 diabetes: A 12-month pilot trialEvan J H Lewis, Bruce A Perkins, Leif E Lovblom, et al.Pageof 45